Quarterly earnings of Perimeter Medical reach preliminary $500,000, marking a 100% increase year over year
Perimeter Medical Imaging AI, a Canadian company specialising in advanced intraoperative imaging technologies, has announced its financial results for the second quarter of 2025. The company's stock is traded on the TSX Venture Exchange under the symbol PINK.
In the first half of 2025, Perimeter Medical Imaging AI showed a financial performance characterised by modest revenue and operational cost reductions, with growth driven by procedure volume and recurring revenues. The Q2 2025 revenue was approximately $500,000 USD, representing a doubling compared to earlier periods, driven by increased procedure volumes and recurring revenue streams.
The gross margin growth in Q2 and H1 2025 is attributed to increased utilization and pricing of the Perimeter S-Series intraoperative imaging system. However, specific gross margin details for Q1 and Q2 2025 were not disclosed in the available data.
Contributing to Perimeter's financial performance are several growth factors. The expansion of the commercial sales pipeline, with a clear focus on scaling sales and growth opportunities, plays a significant role. Cost management efforts led to an approximate 30% reduction in operating costs as part of the company’s strategy to improve profitability. Increased procedure and recurring revenue volumes support a positive revenue trajectory in Q2 2025.
Perimeter Medical Imaging AI continues to develop advanced imaging technologies, including an FDA-cleared OCT system and an investigational AI-enhanced device, supporting its market positioning. However, detailed profit metrics and exact Q1 revenue figures remain undisclosed in the sources provided.
In addition, Perimeter Medical Imaging AI anticipates a gross margin of 69% for Q2 2025 and 61% for H1 2025. The revenue growth is attributed to an over 35% increase in procedures and an over 50% increase in recurring revenue versus Q1 2025, representing a doubling compared to the same period in the previous year.
The company has also announced a $2.5M public offering, but the reasons behind this offering were not provided in the press release. No further financial projections for Q2 2025 or beyond were mentioned in the information provided.
[1] Perimeter Medical Imaging AI Inc. (2025). Perimeter Medical Imaging AI Reports Q2 2025 Financial Results. [Press Release] [2] Perimeter Medical Imaging AI Inc. (2025). Perimeter Medical Imaging AI Provides Corporate Update and Q2 2025 Financial Outlook. [Press Release] [3] Perimeter Medical Imaging AI Inc. (2025). Perimeter Medical Imaging AI Announces Q2 2025 Revenue Guidance. [Press Release] [4] Perimeter Medical Imaging AI Inc. (2025). Perimeter Medical Imaging AI Announces $2.5M Public Offering. [Press Release] [5] Perimeter Medical Imaging AI Inc. (2025). Perimeter Medical Imaging AI to Present at the LD Micro Main Event on June 8, 2025. [Press Release]
In the midst of its focus on scaling sales and growth opportunities, Perimeter Medical Imaging AI has stated a projected gross margin of 69% for Q2 2025, with an aim to improve profitability through cost management efforts that led to an approximate 30% reduction in operating costs. This Canadian company specializing in advanced intraoperative imaging technologies is also planning to raise $2.5M through a public offering, but the reasons behind this move remain undisclosed. [finance, investing, business]
